Heartfelt with Dr Melissa Walton-Shirley

 
 
  • ACC 2019 Burnout: Is the Red Tide Finally Beginning to Turn? Burned out listening to burn-out talks? An intense session at ACC.19 left Melissa Walton-Shirley, MD, hopeful that some of those words would finally turn into action.
  • Beyond Go Red: The Lessons From Susan Lucci’s ACS The All My Children star experienced acute coronary syndrome last fall. After 15 years of Go Red for Women, why are we still missing heart disease in a postmenopausal septuagenarian, asks Dr Walton-Shirley.
  • Time to Eliminate Ageism and Sexism in Medicine The #MeToo movement prompts Melissa Walton-Shirley to reflect on the sexism she dismissed in her early career and the ageism she sees around her now.
  • Advice for Anyone Contemplating Locum Tenens Work After quitting full-time practice, Melissa Walton-Shirley, MD, joined the ranks of medical temp workers. Here's her advice on getting started.
  • AHA 2018 What's Needed After AHA 2018? ACTION A sparsely attended session on social determinants of health sounded very familiar to Melissa Walton-Shirley, MD. So if we know what to do to improve CV health, why haven’t we done it yet?
  • AHA 2018 Glad Your EF Is Better, But Stay on Your Meds While the TRED-HF trial may not be great news for patients with dilated cardiomyopathy and recovered EF, at least it eases this physician's conscience about her reluctance to curtail pharmacotherapy.
  • AHA 2018 Lipid Lollapalooza at AHA 2018 The release of the 2018 cholesterol guidelines and a bunch of lipid-oriented trials made it a bountiful day at the American Heart Association meeting for Melissa Walton-Shirley, MD.
  • Echocardiography: The Good, the Bad, and the Ugly Echocardiography is a great tool when used appropriately, but Melissa Walton-Shirley, MD, finds that poor-quality images and scanty reports often cause more confusion than clarity.
  • Closing the Office Door for the Last Time With a heavy heart, Melissa Walton-Shirley bids farewell to full-time practice. Ailing parents and RVU demands drive this transition to a new stage in her career.
  • ESC 2018 Do Cardiologists Care About CV Prevention? Everyone agrees that prevention is better than cure. However, few ESC attendees joined Melissa Walton-Shirley for the session on CVD prevention, preferring to stand in line to hear the latest hotlines.
  • ESC 2018 Cardiology 2028: Predicting the Future Melissa Walton-Shirley attended a session at the European Society of Cardiology Congress titled "Cardiology 10 Years From Now" and heard some realistic predictions.
  • ESC 2018 What's Driving Physician Burnout in 2018? At a session on burnout at the ESC meeting in Munich, Dr Walton-Shirley heard a first-hand account of a cardiologist who had a breakdown. The panelists left her hopeful that things will improve.
  • ESC 2018 Overprescribing in the Elderly: We Have a Problem Melissa Walton-Shirley sat in on a presentation about polypharmacy in older patients and learned some surprising statistics.
  • When EHRs (and Doctors) Don't Communicate With Each Other When requests for medical records draw no response, time and money are wasted. Can't we do better in the age of electronic health records, asks Melissa Walton-Shirley.
  • Pricey Pee: Time to Regulate Vitamin and Dietary Supplements Multiple studies show that dietary supplements result in little more than expensive urine and in some cases may even cause harm. Melissa Walton-Shirley thinks it's high time they were better regulated.
  • The Death of Yarushka Rivera: Prior Authorization Run Amok A teen suffered tragic consequences from a failed prior authorization; Melissa Walton-Shirley says lawsuits miss the mark.
  • IV Diltiazem and Other Shortages at Crisis Level A confluence of factors, including a hurricane, have left hospitals with shortages of saline and IV drugs. But long-term solutions will require the intervention of legislators, concludes Melissa Walton-Shirley, MD.
  • For the Quadruple Aim to Succeed, Keep Doctors Doctoring An article by the ACC president on helping cardiologists find work-life balance leads Dr Walton-Shirley to detail what exactly needs to happen to make it a reality vs wishful thinking.
  • ACC 2018 MOMENTUM-3: The Future of the LVAD Is Here and Now A trial showing better outcomes for HeartMate 3 over HeartMate II sends Dr Walton-Shirley down memory lane to recall the patients she has referred for implantation of a left ventricular assist device (LVAD).
  • ACC 2018 Another Way to Save a Life: the MANAGE Trial Dr Walton-Shirley was impressed by a study on dabigatran for myocardial injury after noncardiac surgery at the American College of Cardiology Annual Scientific Session.